AI
Monday, May 17, 2021 2:54:00 PM
Coronavirus cases are plummeting in India thanks to new rules that promote Ivermectin and hydroxychloroquine to its massive population.
Of course, the WHO and pharmaceutical companies are having fits.
This is despite the fact that lives are being saved.
The India health ministry updated its guidelines on April 28 for quarantines, treating the asymptomatic and those with mild symptoms of COVID-19. The agency now says that asymptomatic patients should “consider Tab Ivermectin (200 mcg/kg once a day, to be taken empty stomach) for 3 to 5 days.” Caregivers of patients in quarantine are instructed to “take Hydroxychloroquine prophylaxis as per protocol and as prescribed by the treating medical officer.”
There are 292 studies (219 are peer-reviewed) proving the effectiveness of hydroxychloroquine as both a treatment and prophylaxis against COVID-19. Ivermectin has 93 studies (54 peer-reviewed) showing its effectiveness as treatment and prophylaxis against COVID-19. Despite the now-indisputable fact that these drugs essentially kill COVID-19 within hours or days, the Bill Gates-funded World Health Organization (WHO) and big pharma are having fits over India’s new guidelines and the results.
And now the COVID cases are plummeting.
Recent MRNA News
SANUWAVE Announces Reverse Stock Split, Note and Warrant Exchange, and PIPE Offering • SNWV • Oct 18, 2024 9:31 AM
Vocodia Addresses Recent Stock Price Movement and Future Strategic Partnerships • VHAI • Oct 18, 2024 9:00 AM
Mass Megawatts Announces the Start of an Online Discount Solar Energy Equipment Business with Revenue Recognized for the First Time Since Year 2010 in this Fiscal Quarter • MMMW • Oct 18, 2024 7:32 AM
Unitronix Corp Advances DeFi Innovation with Tokenized Real-World Assets Integration • UTRX • Oct 17, 2024 7:38 AM
Mass Megawatts Commences Solar Energy Sales Efforts • MMMW • Oct 16, 2024 7:45 AM
SANUWAVE Health Announces 1-For-375 Reverse Stock Split • SNWV • Oct 16, 2024 7:40 AM
